ANIX•benzinga•
Anixa Biosciences Receives A Notice Of Allowance From The United States Patent And Trademark Office For A New Patent Application Covering Its Chimeric Antigen Receptor-T Cell Technology
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 14, 2025 by benzinga